logo
Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?
TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TB
HIV-1 viral infectivity factor interacts with microtubule-associated protein light chain 3 and inhibits autophagy
Increased carotid intima–media thickness is not associated with T-cell activation nor with cytomegalovirus in HIV-infected never-smoker patients
Early viral suppression improves neurocognitive outcomes in HIV-infected children
HAART slows progression to anal cancer in HIV-infected MSM
Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV
Antiretroviral therapy reduces neurodegeneration in HIV infection
Drug resistance and plasma viral RNA level after ineffective use of oral pre-exposure prophylaxis in women
Modelling the HIV epidemic among MSM in the United Kingdom
Tuberculosis incidence after 36 months’ isoniazid prophylaxis in HIV-infected adults in Botswana
Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia
Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients
Heroin use in Indonesia is associated with higher expression of CCR5 on CD4+ cells and lower ex-vivo production of CCR5 ligands
Seven years of chronic hepatitis C virus infection in an HIV-infected man without detectable antibodies
Acute pancreatitis associated with dolutegravir and lamivudine/abacavir administration
Changes in kidney function in patients with suppressed HIV RNA who substitute their protease inhibitor with atazanavir/ritonavir